USD 2.4
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -41.42 Million CAD | -105.96% |
2022 | -20.11 Million CAD | -7.32% |
2021 | -18.74 Million CAD | -2668.39% |
2020 | -677 Thousand CAD | 96.54% |
2019 | -19.55 Million CAD | -423.6% |
2018 | -3.73 Million CAD | -489.4% |
2017 | 958.83 Thousand CAD | -40.94% |
2016 | 1.62 Million CAD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 3.1 Million CAD | -21.3% |
2024 Q3 | 3.05 Million CAD | -1.71% |
2024 Q1 | 3.94 Million CAD | 238.97% |
2023 Q3 | 651 Thousand CAD | 142.69% |
2023 Q4 | 1.16 Million CAD | 78.96% |
2023 FY | -41.42 Million CAD | -105.96% |
2023 Q2 | -1.52 Million CAD | 48.43% |
2023 Q1 | -2.95 Million CAD | 15.68% |
2022 Q2 | -6.72 Million CAD | -9.32% |
2022 FY | -20.11 Million CAD | -7.32% |
2022 Q4 | -3.5 Million CAD | 25.48% |
2022 Q3 | -4.7 Million CAD | 29.97% |
2022 Q1 | -6.14 Million CAD | -26.72% |
2021 Q4 | -4.85 Million CAD | 33.25% |
2021 FY | -18.74 Million CAD | -2668.39% |
2021 Q1 | -2.04 Million CAD | -457.52% |
2021 Q2 | -4.51 Million CAD | -120.59% |
2021 Q3 | -7.26 Million CAD | -61.1% |
2020 Q3 | 2.11 Million CAD | 3601.75% |
2020 Q4 | 572 Thousand CAD | -72.89% |
2020 FY | -677 Thousand CAD | 96.54% |
2020 Q1 | -1.94 Million CAD | 70.68% |
2020 Q2 | 57 Thousand CAD | 102.93% |
2019 Q1 | -5 Million CAD | -64.6% |
2019 FY | -19.55 Million CAD | -423.6% |
2019 Q4 | -6.62 Million CAD | -64.09% |
2019 Q3 | -4.03 Million CAD | 11.87% |
2019 Q2 | -4.58 Million CAD | 8.42% |
2018 Q2 | -721 Thousand CAD | -255.19% |
2018 Q4 | -3.03 Million CAD | -329.95% |
2018 FY | -3.73 Million CAD | -489.4% |
2018 Q1 | 464.58 Thousand CAD | 45.28% |
2018 Q3 | -707 Thousand CAD | 1.94% |
2017 Q3 | 756.68 Thousand CAD | 0.0% |
2017 Q4 | 319.77 Thousand CAD | -57.74% |
2017 FY | 958.83 Thousand CAD | -40.94% |
2016 FY | 1.62 Million CAD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
CannBioRx Life Sciences Corp. | -13.47 Million USD | -207.364% |
China Jo-Jo Drugstores, Inc. | -3.53 Million USD | -1071.998% |
Harrow Health, Inc. 8.625% Senior Notes due 2026 | 580 Thousand USD | 7242.241% |
Harrow Health, Inc. 11.875% Senior Notes due 2027 | 431 Thousand USD | 9711.369% |
Leafly Holdings, Inc. | -7.05 Million USD | -487.505% |
LifeMD, Inc. | -14.48 Million USD | -185.901% |
LifeMD, Inc. | -14.48 Million USD | -185.901% |
TRxADE HEALTH, Inc. | -7.26 Million USD | -470.325% |
PetMed Express, Inc. | -8.16 Million USD | -407.535% |
Walgreens Boots Alliance, Inc. | -14.07 Billion USD | 99.706% |